Chris Miller's Article "Achieving Approval for Abuse-Deterrent Opioids in the era of an Opioid Epidemic" Published in The Pharma Letter
Source: 3D Communications
We are proud to announce that today The Pharma Letter published an article written by Chris Miller. It’s entitled:Achieving approval for abuse-deterrent opioids in the era of an opioid epidemic.
In this article, Chris provides his perspective on the regulatory challenges pharmaceutical companies face as they try to get abuse-deterrent opioid products approved. In keeping with the 3D mission of providing solutions for problems – Chris offers companies tips on how to address those challenges.
Read the article here.
3D Communications is a strategic communications firm that prepares pharmaceutical and device companies for high-stakes regulatory, payer, and other stakeholder interactions. 3D offers a comprehensive and integrated approach to defining, supporting, and articulating value throughout all stages of product development.